Oscar Health
OSCR • NYSE
Oscar Health is a medical - healthcare plans company in the healthcare sector trading on NYSE, led by CEO Mark Thomas Bertolini, with a market cap of $3.3B.
CEOMark Thomas Bertolini
Next Earnings
Upcoming earnings announcement for Oscar Health
Date
Wednesday, May 6, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.21
Revenue Estimate
$4.9B
Earnings History
Past 12 earnings reports for Oscar Health
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Q4 2025 | -$1.24Est: -$0.89 | -39.3% | $2.8BEst: $3.2B | -11.2% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.53Est: -$0.57 | +7.0% | $3.0BEst: $3.1B | -3.2% | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.89Est: -$0.86 | -3.5% | $2.9BEst: $2.9B | -1.6% | 10-Q |
| May 7, 2025 | Q1 2025 | $0.92Est: $0.81 | +13.6% | $3.0BEst: $2.9B | +6.1% | 10-Q |
| Feb 4, 2025 | Q4 2024 | -$0.62Est: -$0.58 | -6.9% | $2.4BEst: $2.5B | -3.2% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.22Est: -$0.17 | -29.4% | $2.4BEst: $2.3B | +3.5% | 10-Q |
| Aug 7, 2024 | Q2 2024 | $0.20Est: $0.15 | +33.3% | $2.2BEst: $2.2B | +2.3% | 10-Q |
| May 7, 2024 | Q1 2024 | $0.62Est: $0.27 | +129.6% | $2.1BEst: $2.0B | +6.6% | 10-Q |
| Feb 7, 2024 | Q4 2023 | -$0.66Est: -$0.72 | +8.3% | $1.4BEst: $1.4B | +0.8% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.29Est: -$0.51 | +43.1% | $1.4BEst: $1.4B | +1.4% | — |
| Aug 8, 2023 | Q2 2023 | -$0.07Est: -$0.27 | +74.1% | $1.5BEst: $1.4B | +5.6% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.18Est: -$0.05 | -260.0% | $1.5BEst: $1.2B | +27.8% | — |